✦ LIBER ✦
Adding cetuximab to a standard chemotherapy regimen containing bevacizumab in first-line therapy for colorectal cancer decreases efficacy: Results from the CAIRO2 trial
✍ Scribed by Axel Grothey
- Book ID
- 107535720
- Publisher
- Current Science Inc.
- Year
- 2009
- Tongue
- English
- Weight
- 174 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1556-3790
No coin nor oath required. For personal study only.